A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs
NY TimesPaywall
Read Full Article at NY Times →Ad Slot — In-Article (728x90)
Rasonque, the new pancreatic cancer treatment from Revolution Medicines, illustrates the huge inflation in cancer drug prices over the past two decades.
This is a summary. For the full story, read the original article at NY Times.
Original source: NY Times